Tag: "announced" at medical news

Elan and Biogen Idec announce results from Phase III maintenance trial of Antegren

...AY 18, 2004 Elan Corporation, plc and Biogen Idec announced that in a Phase III maintenance study, ANTEGREN (natalizumab) maintained clinical response and remission rates throughout six months among patients with Crohn's disease (CD) who had previously achieved clinical response. Additionally, a majority of ...

Hebrew University one of 25 institutions involved in new European Vascular Genomics Network

...omics Network (EVGN), whose operational launch was announced this week by Inserm, the French National Institute of Health and Medical Research. EVGN is the first European Union-funded network in the field of cardiovascular diseases. The project is intended to integrate post-genomic research into the more esta...

ESC highlights need for screening and global risk management as statins move over the counter in UK

... the Health Secretary for the United Kingdom (UK), announced the reclassification of statins as 'over the counter' products in the UK, to be available to members of the public directly from pharmacists without the need for a prescription. With this move, recently approved by the UK's Committee on Safety of Me...

Medical College of Georgia to establish clinical campus at Phoebe Putney Memorial Hospital

...ces university and the Albany-based hospital today announced the creation of the Medical College of Georgia Clinical Campus at Albany. The two organizations are in the final stages of formalizing the agreement. The Albany Clinical Campus, which will be located at Phoebe Putney Memorial Hospital, is designed t...

News briefs from the journal CHEST, May 2004

...ge of Chest Physicians (ACCP), the medical society announced an initiative to have its members embrace the concept of patient-focused care. The report features the inauguration speech of Richard S. Irwin, MD, FCCP, President of the ACCP, and the new ACCP Patient-Focused Care Pledge, which emphasizes the healt...

New data shows Seroquel achieves remission in bipolar mania

...ark, England — May 7, 2004 — AstraZeneca announced important new data today that show patients with bipolar disorder who were treated with SEROQUEL (quetiapine) were significantly more likely to achieve full remission of their mania symptoms compared to patients who received placebo. 1 The data were...

American Academy of Neurology sums up scientific highlights from 56th Annual Meeting

...c findings regarding Parkinson's disease (PD) were announced at the meeting. Specific forms of the ApoE gene have long been known to affect risk for Alzheimer's disease. By combining results from 20 studies on ApoE in PD, researchers from the University of North Carolina showed that ApoE-2 increases the risk f...

Max daily OTC dose of acetaminophen shows efficacy comparable to Rx doses of naproxen for OA pain

VANCOUVER, BC (May 7, 2004)Researchers today announced new clinical evidence showing that long-term use of maximum recommended over-the-counter (OTC) daily doses of acetaminophen (APAP) provide efficacy comparable to prescription doses of naproxen (NAP) for the management of mild-to-moderate osteoarthri...

Seroquel: New data show efficacy and tolerablity in bipolar depression

...ark, England — May 6, 2004 — AstraZeneca announced important new data today presented at the 157th American Psychiatric Association (APA) congress from the first large-scale clinical trial to examine SEROQUEL (quetiapine) as a treatment for depressive episodes in patients with bipolar I and II disord...

Long-term study proves ADDERALL XR is a safe and effective option to treat adults with ADHD

...Group plc (NASDAQ: SHPGY, LSE: SHP.L, TSE: SHQ CN) announced that adults with attention-deficit/hyperactivity disorder (ADHD) experienced significant ADHD symptom control when treated with once-daily ADDERALL XR (a mixed salts amphetamine product). The 18-month interim analysis of a two-year Phase III trial l...

Rising young psychiatry researchers receive prestigious international award

...sychiatric Association (APA) and AstraZeneca today announced the winners of their prestigious 2003 'Young Minds in Psychiatry Awards Programme' at the APA's Young Researchers Breakfast event, held to coincide with their 157th annual meeting. The Awards Programme, an annual commitment by the two organisations, ...

North Shore-LIJ attains accreditation of human research protections processes

...Shore-Long Island Jewish (LIJ) Health System today announced accreditation of a major arm of its human research protections processes by the Partnership for Human Research Protections (PHRP). A watchdog group, PHRP is a joint collaboration of the two most trusted names in healthcare quality and safety -- the J...

NIAID rotavirus vaccine licensed for commercialization

..., part of the National Institutes of Health (NIH), announced today a new license agreement aimed at helping to prevent hundreds of thousands of deaths annually from rotavirus diarrhea in children living in developing countries. An effective oral rotavirus vaccine--created by NIAID scientists in the mid- to lat...

REI medical/research briefs

...on Institute (REI) at Harbor UCLA Medical Center, announced that it has initiated a Phase II trial of a new anthrax vaccine, rPA102 (VaxGen, Inc.). The 13-month trial is taking place at 12 medical centers in the United States and is one of two studies of rPA102 initiated this year under a multi-year, $80.3 m...

FDA approves Enbrel to treat psoriasis

...OLLEGEVILLE, Pa., April 30, 2004 Amgen (N), today announced that Enbrel® (etanercept) has been approved by the U.S. Food and Drug Ad ASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYEministration (FDA) for the treatment of adult patients (18 years or older) with chronic moderate to sev...

Presence of gene mutation tightly linked to drug effectiveness in lung cancer

...l Institutes of Health and two other institutions announced today in the online version of Science*. Previously, gefitinib had been shown to cause tumor regression in certain patients, but researchers had not been able to predict which patients would be responsive to the drug. With this discovery, doctors w...

VELCADE (Bortezomib) receives European marketing authorisation

...biopharmaceutical division of Janssen-Cilag, today announced that the European Commission has issued a positive decision for VELCADE, a new treatment for multiple myeloma, a form of blood cancer. The novel drug is indicated to treat multiple myeloma patients who have received at least two prior therapies and ...

Space solutions for health

ESA today announced the launch of its 'Space Solutions' initiative, a ... industries in the wellness market. The launch was announced at an event featuring an address by ESA astronaut Andr Kuipers, live from the International Space St...

VA's newest manufacturer has microscopic product line

...y pioneer Luna Innovations of Blacksburg, Va., has announced that it plans to establish a nanomanufacturing facility in Danville, Va. The plant will produce novel "buckyball" materials for medical diagnostics and other military and commercial applications. This technology was developed in part with a 2001 awar...

Phase II trial of anthrax vaccine to begin

...on Institute (REI) at Harbor UCLA Medical Center, announced today that it has initiated a Phase II trial of a new anthrax vaccine, rPA102 (VaxGen, Inc.). The 13-month trial is taking place at 12 medical centers in the United States and is one of two studies of rPA102 initiated this year under a multi-year, $...

1 2 3 4 5 6 7 8 9 10

(Date:11/27/2014)... According to a recent report by iData ... into the surgical robotics market may find ... MIS field dominated by Intuitive. These companies are expected ... market by 2020. , “The MIS robotic device ... and President of iData. “System sales for the da ...
(Date:11/27/2014)... An inventor from Buffalo, N.Y., knows that many ... she wants to lessen its impact. "After showering and ... there needed to be a way to maintain freshness ... and producible in design variations, the End Scentuous Body ... the day. It avoids bad odors, as well as ...
(Date:11/27/2014)... HealthDay Reporter WEDNESDAY, Nov. 26, 2014 ... safe and produces an immune system response that could protect ... results reported by the U.S. National Institutes of Health. ... vaccine paves the way for field-testing it in the Ebola-stricken ... as January, said Dr. Anthony Fauci, director of the NIH,s ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 Now that ... season has officially launched, Emassagechair.com has announced ... Monday Discount Event. , Negotiating on behalf of ... top massage chair brands, Emassagechair.com has generated significant buzz ... deals and biggest discounts yet. , Shoppers are excited ...
(Date:11/27/2014)... “LAB.C” was featured on NewsWatch as part ... coolest technology products available to consumers. Mallory Sofastaii, a technology ... and shared with viewers the company offers a cable ... , Consumers love portability and functionality. A unique mobile ... the iPhone5 and 5S has a portable USB charger built ...
Breaking Medicine News(10 mins):Health News:U.S. Robotic Surgery Market Set to Diversify and Grow: Intuitive Surgical’s ‘da Vinci’ Robot Revenues to Increasingly Rely On Procedures and Services 2Health News:Early Trial Promising for Ebola Vaccine 2Health News:Early Trial Promising for Ebola Vaccine 3Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 2Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 3Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 4Health News:Top Mobile Friendly Accessories were Featured on NewsWatch Television on October 30, 2014 2
Other Tags
camerasfeaturebiophysicistsadhereseedsfourcloudylionstailoringteacherscouncildairyeczemacircleparliamentcapital